EXHIBIT 11 BOSTON BIOMEDICA, INC. AND SUBSIDIARIES STATEMENT RE COMPUTATION OF INCOME PER SHARE WEIGHTED AVERAGE SHARES Quarter Ended September 30, Nine Months Ended September 30, --------------------------- ------------------------------- 1997 1996 1997 1996 ------------- ------------ -------------- -------------- Average common stock outstanding 4,437,556 2,690,064 4,407,158 2,628,841 Net effect of dilutive common stock equivalents-based on treasury stock method using average market price 365,322 623,044 397,784 623,044 ------------- ------------ -------------- -------------- 4,802,878 3,313,108 4,804,942 3,251,885 ============= ============ ============== ============== Net income $246,147 $162,652 $569,596 $245,521 Add: net reduction of interest on debt, less 40% taxes - 10,450 - 10,450 Adjusted net income (loss) for earnings per share calculation $246,147 $173,102 $569,596 $255,971 ============= ============ ============== ============== Net income per share 0.05 0.05 0.12 0.08 ============= ============ ============== ============== 16